Through a series of genetic modified mouse models, Jiang et al. (27–29) demonstrated that IRF7, IRF8, and IRF9 were anti-hypertrophy factors consistently down-regulated in cardiac hypertrophy and heart failure. The gene discussed is IRF8; the disease is cardiac hypertrophy.